However, in people with mild cognitive impairment, the presence of depressive symptoms was tied to a lower likelihood of amyloid pathology (OR 0.73, 95% CI 0.61-0.89, P =0.001), Oomens and colleagues ...
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback